Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $4.78 USD
Change Today 0.00 / 0.00%
Volume 122.7K
NEO On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 8:10 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

George A. Cardoza

Chief Financial Officer, Neogenomics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

52$325,806
As of Fiscal Year 2013

Background*

Mr. George A. Cardoza has been the Chief Financial Officer of Neogenomics Inc., since November 2009. Mr. Cardoza served as the Chief Financial Officer of Neogenomics Laboratories, Inc. He served as an Executive Vice President and Chief Financial Officer of Protocol Services Acquisition Corp. Mr. Cardoza joined NeoGenomics in November 2009. He has over 25 years of financial experience. He most recently served as Chief Financial Officer and Executive Vice President of ...

Read Full Background

Corporate Headquarters*

12701 Commonwealth Drive
Fort Myers, Florida 33913

United States

Phone: 239-768-0600
Fax: 239-690-4237

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Syracuse University
MBA
Michigan State University

Other Affiliations*

Annual Compensation*

Salary$245,500
Bonus$60,000
Total Annual Compensation$305,500

Stock Options*

Exercised Options20,000
Exercised Options Value$42,000
Exercisable Options205,000
Unexercisable Options25,000
Total Value of Options$42,000
Total Number of Options250,000

Total Compensation*

Total Annual Cash Compensation$310,090
Total Short Term Compensation$305,500
Total Calculated Compensation$325,806
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEO:US $4.78 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
$555.5K
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
$536.9K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
$800.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Samuel D. Riccitelli Chief Executive Officer, President and Director
Signal Genetics, Inc.
$469.8K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGENOMICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.